Accelerated payout opportunity is available on Risperdal contract

LAS VEGAS - March 24, 2014 - PRLog -- Accelerated payout being offered on Risperdal Prepaid Forward Contract.  Minimum investment is $250,000 maximum $4,000,000.  This offer will close once an aggregate amount of $4M has been contributed.

Payout is acclerated at 24 months, with $1M being returned to each participating funder for each $250,000 contributed.


Litigation Funding involves the medical device and pharmaceutical industry, where certain of these companies’ products have been found to have defects which have, in turn, resulted in injuries and health issues. These companies have lost suits, resulting in the companies having been ordered to set aside significant monies in trust, from which they will pay claimants as they come forward. The amount of these settlements are often hundreds of millions or even over a billion dollars. The claimants who have suffered damages usually collect sizeable settlements.

To better understand the opportunity for a funder to participate in Litigation Funding, let’s look at a hypothetical, but typical situation. On television, the radio or newspapers or magazines, you’ve probably seen or heard advertisements asking anyone who has suffered damages from specific pharmaceuticals or medical devices to come forward and contact a law firm to collect on a settlement.

In our example, a fictional pharmaceutical company, XYZ Medical Inc., has manufactured a prescription drug for the treatment of depression, called Medex.

As a result, there is no trial and there are no appeals. The money has already been allocated for claimants to come and receive their settlements. We want to drive this point home. After a time it is discovered that Medex causes severe heart and lung disorders. XYZ has been sued by a law firm, lost its case and the

settlement amount, which is over-seen by the courts, is placed into a

settlement trust account. The law firm collects the settlement and pays each claimant, damaged by Medex, his or her settlement share.

That’s how it works and that’s where the transaction ends, up until now that is.

As you might imagine, there are considerable expenses to the law firm associated with locating claimants who have suffered damages. Continual television, radio, newspaper and magazine "marketing" efforts are very expensive. On top of these costs, the law firm, before claimants are considered qualified to receive their settlements, often have to pay for the claimant’s medical records, examinations and even occasional reversionary surgeries.

In our example, let’s say this sum is one billion dollars. XYZ knows that

thousands of claimants will be coming forth to receive their settlements.

So these are in counter-distinction to class action suits, where on-going litigation and appeals can drag on for years. To re-iterate, these medical companies have already lost these individual lawsuits and have set aside the settlement funds for claimants.

http://newyork.legalexaminer.com/fda-prescription-drugs/plaintiff-claims-risperdal-gynecomastia-in-ca-lawsuit/


Johnson and Johnson required to pay Record $2.2B in Risperdal Lawsuit:

http://www.lawyersandsettlements.com/settlements/17589/johnson-to-pay-record-2-2b-in-risperdal.html#.UymeZlepupB